EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug repositioning for pan-cancers of the digestive system: Identification of amonafide and BX795 as potential therapeutics via integrative Omics analysis

Weidong Liu, Jiaying Gao, Shuqiang Ren, Buhe Nashun, Fei Gao iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0325700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Weidong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genome Analysis Laboratory of the Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricult…. Hauptthemen laut MEDLINE: Drug Repositioning, Antineoplastic Agents, Digestive System Neoplasms. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leading the Charge with Open Competition’ project of Inner Mongolia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Digestive system cancers, including esophageal, gastric, colorectal, pancreatic, hepatocellular, and biliary tract cancers, constitute a major global health challenge. Despite therapeutic advancements, prognosis remains poor, highlighting the urgent need for novel treatment strategies. We hypothesized that drug repositioning, facilitated by pan-cancer analyses, could lead to the identification of effective treatment strategies for these cancers.

Results

We performed a comprehensive gene expression profiling of six major digestive system cancer types using The Cancer Genome Atlas data. Through integrative omics analysis, we identified 9,978 shared differentially expressed genes (DEGs) between colorectal cancer (CRC) and liver hepatocellular carcinoma (LIHC). Functional enrichment analysis revealed nine common Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, with Cell Cycle being a significant shared pathway. Protein-protein interaction (PPI) network analysis identified core genes within these pathways, including CCNE1, CHEK1, NXF1, NCBP2, and RPS27A. A Connectivity Map (CMap) analysis matched 1,147 small molecules, leading to the identification of Amonafide and BX795 as top candidates. These two drugs were validated and shown to inhibit the proliferation and migration of CRC (HT-29) and LIHC (HepG2) cells and induce cell cycle arrest and apoptosis.

Conclusion

Our study demonstrates the utility of drug repositioning for identifying potential therapeutics for digestive system cancers. Amonafide and BX795 emerged as promising candidates in targeting both CRC and LIHC. Further in vivo studies and clinical trials are warranted to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningAntineoplastic AgentsDigestive System NeoplasmsHumansProtein Interaction MapsGene Expression Regulation, NeoplasticGene Expression ProfilingCell ProliferationCell Line, TumorLiver NeoplasmsCell MovementCarcinoma, HepatocellularGene Regulatory NetworksMultiomics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Genome Analysis Laboratory of the Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen, China.
  • Inner Mongolia Key Laboratory for Molecular Regulation of the Cell, Inner Mongolia University, Hohhot, China.
  • State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, School of Life Sciences, Inner Mongolia University, Hohhot, China.

ORCID-Profile: Fei Gao

Förderung

  • Leading the Charge with Open Competition’ project of Inner Mongolia

Zitieren

APA

Liu, W., Gao, J., Ren, S., Nashun, B., & Gao, F. (2025). Drug repositioning for pan-cancers of the digestive system: Identification of amonafide and BX795 as potential therapeutics via integrative Omics analysis. PLOS One. https://doi.org/10.1371/journal.pone.0325700

Vancouver

Liu W, Gao J, Ren S, Nashun B, Gao F. Drug repositioning for pan-cancers of the digestive system: Identification of amonafide and BX795 as potential therapeutics via integrative Omics analysis. PLOS One. 2025. doi:10.1371/journal.pone.0325700

BibTeX
@article{Liu2025,
  author = {Liu, Weidong and Gao, Jiaying and Ren, Shuqiang and Nashun, Buhe and Gao, Fei},
  title = {Drug repositioning for pan-cancers of the digestive system: Identification of amonafide and BX795 as potential therapeutics via integrative Omics analysis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325700}
}
Kostenlos starten →